Latest papers

Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo.

Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01.

Human monoclonal antibodies to the insulin-like growth factor 1 receptor inhibit receptor activation and tumor growth in preclinical studies.

Affinity maturation of an anti-V antigen IgG expressed in situ through adenovirus gene delivery confers enhanced protection against Yersinia pestis challenge.

Contribution of light chain residues to high affinity binding in an HIV-1 antibody explored by combinatorial scanning mutagenesis.

Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response.

A differential cell capture assay for evaluating antibody interactions with cell surface targets.

Manipulating antigenic ligand strength to selectively target myelin-reactive CD4+ T cells in EAE.

Antibody recognition of a unique tumor-specific glycopeptide antigen.

Construction of a humanized antibody to hepatitis B surface antigen by specificity-determining residues (SDR)-grafting and de-immunization.

A novel antibody avidity methodology for rapid point-of-care serological diagnosis.

Correlation between the composition of multivalent antibody conjugates with colloidal gold nanoparticles and their affinity.

Dating of human bocavirus infection with protein-denaturing IgG-avidity assays-Secondary immune activations are ubiquitous in immunocompetent adults.

Rates and equilibria for probe capture by an antibody with infinite affinity.

Congenital toxoplasmosis transmitted by human immunodeficiency-virus infected women.

Evaluation of indirect enzyme-linked immunosorbent assays and IgG avidity assays using a protein A-peroxidase conjugate for serological distinction between Brucella abortus S19-vaccinated and -infected cows.

Targeting very small model lesions pretargeted with bispecific antibody with 99mTc-labeled high-specific radioactivity polymers.

[Identification and production of monoclonal antibody of Siberian tiger's immunoglobulin].

Engineering of stable bispecific antibodies targeting IL-17A and IL-23.

Biodistribution mechanisms of therapeutic monoclonal antibodies in health and disease.